- Home
- CBAN vs MRVI Comparison
CBAN vs MRVI Comparison
Compare CBAN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAN
- MRVI
- Stock Information
- Founded
- CBAN 1975
- MRVI 2014
- Country
- CBAN United States
- MRVI United States
- Employees
- CBAN N/A
- MRVI N/A
- Industry
- CBAN Major Banks
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- CBAN Finance
- MRVI Health Care
- Exchange
- CBAN Nasdaq
- MRVI Nasdaq
- Market Cap
- CBAN 273.0M
- MRVI 312.4M
- IPO Year
- CBAN 1998
- MRVI 2020
- Fundamental
- Price
- CBAN $15.28
- MRVI $2.08
- Analyst Decision
- CBAN
- MRVI Hold
- Analyst Count
- CBAN 0
- MRVI 10
- Target Price
- CBAN N/A
- MRVI $6.84
- AVG Volume (30 Days)
- CBAN 61.4K
- MRVI 1.5M
- Earning Date
- CBAN 07-23-2025
- MRVI 08-06-2025
- Dividend Yield
- CBAN 3.01%
- MRVI N/A
- EPS Growth
- CBAN 14.66
- MRVI N/A
- EPS
- CBAN 1.43
- MRVI N/A
- Revenue
- CBAN $113,756,000.00
- MRVI $241,856,000.00
- Revenue This Year
- CBAN $18.25
- MRVI N/A
- Revenue Next Year
- CBAN $7.59
- MRVI $10.73
- P/E Ratio
- CBAN $10.65
- MRVI N/A
- Revenue Growth
- CBAN 3.33
- MRVI N/A
- 52 Week Low
- CBAN $11.30
- MRVI $1.67
- 52 Week High
- CBAN $18.49
- MRVI $10.03
- Technical
- Relative Strength Index (RSI)
- CBAN 46.87
- MRVI 46.40
- Support Level
- CBAN $14.63
- MRVI $2.00
- Resistance Level
- CBAN $16.16
- MRVI $2.44
- Average True Range (ATR)
- CBAN 0.34
- MRVI 0.15
- MACD
- CBAN -0.03
- MRVI -0.03
- Stochastic Oscillator
- CBAN 29.03
- MRVI 20.45
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.